CA Stock MarketDetailed Quotes

APS Aptose Biosciences Inc

Watchlist
  • 2.910
  • -0.070-2.35%
15min DelayMarket Closed Apr 11 16:00 ET
7.43MMarket Cap-0.06P/E (TTM)

About Aptose Biosciences Inc Company

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Company Profile

SymbolAPS
Company NameAptose Biosciences Inc
Founded2006
MarketTSE
Employees13
Fiscal Year Ends12-31
Address66 Wellington Street West Suite 5300, TD Bank Tower Box 48
CityToronto
CountryCAN
Zip CodeM5K 1E6
Phone+1 647 479-9828

Company Executives

  • Name
  • Position
  • Salary
  • Dr. William G. Rice, PhD
  • Chairman of the Board, President and Chief Executive Officer
  • 924.67K
  • Fletcher Payne
  • Principal Accounting Officer, Senior Vice President, Chief Financial Officer, Corporate Secretary and Chief Business Officer
  • 611.37K
  • Dr. Rafael Bejar, M.D.,PhD
  • Senior Vice President and Chief Medical Officer
  • 750.08K
  • Carol Gail Ashe
  • Independent Director
  • 123.67K
  • Warren Whitehead
  • Independent Director
  • 122.68K
  • Dr. Mark D. Vincent, M.D.
  • Independent Director
  • 127.68K
  • Dr. Erich M. Platzer, M.D.,PhD
  • Independent Director
  • 123.67K
  • Dr. Denis R. Burger,PhD
  • Lead Independent Director
  • 172.17K
  • Dr. Bernd R. Seizinger, M.D.,PhD
  • Independent Director
  • 132.17K

Market Insights

Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.

Unlock Now